Choosing the right angiotensin-receptor blocker for patients with diabetes: still controversial

Por Cooper, Mark E.
Publicado em 2013

Pathogenesis of diabetic nephropathy

Por Cao, Zemin, Cooper, Mark E
Publicado em 2011

Tandem Inhibition of PKC in Diαβetic Nephropathy: It Takes Two to Tango?

Por Thallas-Bonke, Vicki, Cooper, Mark E.
Publicado em 2013

Genetics of Diabetic Kidney Disease—From the Worst of Nightmares to the Light of Dawn?

Por Ma, Ronald C.W., Cooper, Mark E.
Publicado no J Am Soc Nephrol (2017)

PATHOPHYSIOLOGY AND TREATMENT OF TYPE 2 DIABETES: PERSPECTIVES ON THE PAST, PRESENT AND FUTURE

Por Kahn, Steven E., Cooper, Mark E., Del Prato, Stefano
Publicado no Lancet (2013)

Experimental Models of Type-2 Diabetic Nephropathy

Por Tomino, Yasuhiko, Cooper, Mark E., Kurtz, Theodore W., Shimizu, Yoshio
Publicado em 2012

Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation, Fibrosis

Por Toh, Ban-Hock, Tu, Yugang, Cao, Zemin, Cooper, Mark E., Chai, Zhonglin
Publicado em 2010

Set7 mediated interactions regulate transcriptional networks in embryonic stem cells

Por Tuano, Natasha K., Okabe, Jun, Ziemann, Mark, Cooper, Mark E., El-Osta, Assam
Publicado no Nucleic Acids Res (2016)

Diabetes and Kidney Disease: Role of Oxidative Stress

Por Jha, Jay C., Banal, Claudine, Chow, Bryna S.M., Cooper, Mark E., Jandeleit-Dahm, Karin
Publicado no Antioxid Redox Signal (2016)

Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin

Por Sarlos, Stella, Rizkalla, Bishoy, Moravski, Christina J., Cao, Zemin, Cooper, Mark E., Wilkinson-Berka, Jennifer L.
Publicado em 2003

Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy

Por Herman-Edelstein, Michal, Thomas, Merlin C., Thallas-Bonke, Vicki, Saleem, Moin, Cooper, Mark E., Kantharidis, Phillip
Publicado em 2011

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction

Por Groop, Per-Henrik, Cooper, Mark E., Perkovic, Vlado, Emser, Angela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Publicado em 2013

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and li...

Por Mogensen, Carl Erik, Neldam, Steen, Tikkanen, Ilkka, Oren, Shmuel, Viskoper, Reuven, Watts, Richard W, Cooper, Mark E
Publicado em 2000

Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling Pathway

Por Li, Jin H., Wang, Wansheng, Huang, Xiao R., Oldfield, Matthew, Schmidt, Ann M., Cooper, Mark E., Lan, Hui Y.
Publicado em 2004

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

Por El-Osta, Assam, Brasacchio, Daniella, Yao, Dachun, Pocai, Alessandro, Jones, Peter L., Roeder, Robert G., Cooper, Mark E., Brownlee, Michael
Publicado em 2008

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

Por El-Osta, Assam, Brasacchio, Daniella, Yao, Dachun, Pocai, Alessandro, Jones, Peter L., Roeder, Robert G., Cooper, Mark E., Brownlee, Michael
Publicado em 2008

Comparison of Different Measures of Urinary Protein Excretion for Prediction of Renal Events

Por Lambers Heerspink, Hiddo J., Gansevoort, Ron T., Brenner, Barry M., Cooper, Mark E., Parving, Hans Henrik, Shahinfar, Shahnaz, de Zeeuw, Dick
Publicado em 2010

Pathological Expression of Renin and Angiotensin II in the Renal Tubule after Subtotal Nephrectomy : Implications for the Pathogenesis of Tubulointerstitial Fibrosis

Por Gilbert, Richard E., Wu, Leonard L., Kelly, Darren J., Cox, Alison, Wilkinson-Berka, Jennifer L., Johnston, Colin I., Cooper, Mark E.
Publicado em 1999

Genetic Deletion of Cell Division Autoantigen 1 Retards Diabetes-Associated Renal Injury

Por Chai, Zhonglin, Dai, Aozhi, Tu, Yugang, Li, Jiaze, Wu, Tieqiao, Wang, Yu, Hale, Lorna J., Koentgen, Frank, Thomas, Merlin C., Cooper, Mark E.
Publicado em 2013

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

Por Fukami, Kei, Yamagishi, Sho-ichi, Coughlan, Melinda T, Harcourt, Brooke E, Kantharidis, Phillip, Thallas-Bonke, Vicki, Okuda, Seiya, Cooper, Mark E, Forbes, Josephine M
Publicado em 2014